Bioequivalence and Bioavailability Forum

In a clinical trial study where multiple doses are done and evaluation of PK concentration is carried out by 2 different bioanalytical method having different cc range (Low and high) and analysis is being done in different lab (Low cc range in lab 1 and high CC range in lab 2). should we conduct cross validation between both method. If yes then how will be the design of the cross validation.

---

Edit: Please follow the Forum’s Policy. [Helmut]